Patents

Innovation is at the heart of the Institute’s mission to advance mental health and neuro sciences. The dedication to research and development transcends conventional methods, promoting a culture where ground-breaking ideas translate into tangible solutions.

The patents represent significant strides in various fields, from novel diagnostic tools to cutting-edge therapeutic interventions. Each patent reflects the pioneering spirit of the faculty and researchers, who continually push the boundaries of knowledge to improve patient care and outcomes.

Explore the portfolio of innovative solutions developed at NIMHANS that are shaping the future of mental health and medical science.

Patents Awarded/Published

• Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof (WO 2009122444 A3). Dept. of Neuropathology, NIMHANS and CSIR, 2009.
• Use of double micro-catheter technique in management of mural type of vein of Galen formation. Dept. of NIIR, NIMHANS, 2010.
• Combined use of GDC coils and onyx for the treatment of direct carotid cavernous fistula. Dept. of NIIR, NIMHANS, 2010.
• Poly (ether imine) dendrimers and uses thereof (WO 2012090223 A1). Dept. of Neurovirology, NIMHANS and Indian Institute of Science (IISc), 2012.
• TOP2A inhibition by temozolomide useful for predicting GBM patient’s survival (WO 2012038812A2). Dept. of Neuropathology, NIMHANS and Council of Scientific & Industrial Research (CSIR), 2013.
• Micro RNAs (miRNA) as biomarkers for diagnosing different grades of gliomas and pathways of glioma progression (WO 2011121610A1). Dept. of Neuropathology, NIMHANS, Department of Biotechnology (DBT), and Indian Institute of Science (IISc), 2014.
• Multi-institutional network programme in molecular neuro-oncology (Provisional filing). Depts. of Neuropathology, Neurosurgery, Biostatistics, and NIIR, NIMHANS (Funding by DBT).